Faire un don

Mercredi, 21 avril 2021

Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma (en anglais)

Multiple myeloma is a malignancy of plasma cells, which is highly associated with immune suppression. Consistent with this, reports of outcomes of COVID-19 infection in patients with multiple myeloma show higher rates of severe disease than in the general population.

Cliquez ici pour lire la suite (en anglais).